THERAFLU DAYTIME SEVERE COLD & COUGH HOT LIQUID OTC
Generic Name and Formulations:
Acetaminophen 650mg, dextromethorphan HBr 20mg, phenylephrine HCl 10mg; pwd packets; berry infused with menthol and green tea flavors; contains potassium 10mg, sodium 20mg, phenylalanine 14mg per packet.
Novartis Consumer Health
Indications for THERAFLU DAYTIME SEVERE COLD & COUGH HOT LIQUID:
Nasal and sinus congestion, cough, sore throat, fever, headache, minor aches and pains.
Dissolve contents of 1 packet into 8oz hot water; sip while hot. Consume entire drink within 10–15mins. Take every 4 hours; max 6 packets/24hrs.
During or within 14 days of MAOIs. Concomitant other acetaminophen products.
Hepatic dysfunction. Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Asthma. Lower respiratory disorders. Discontinue if symptoms worsen or persist after 2–7 days. Pregnancy. Nursing mothers.
See Contraindications. Hypertensive crisis with MAOIs. Increased risk of hepatotoxicity with ≥3 alcoholic drinks/day; avoid. β-blockers may increase the pressor effects of sympathomimetics. Antihypertensives antagonized.
Analgesic + antitussive + sympathomimetic.
Nervousness, dizziness, insomnia, hepatotoxicity (overdosage).
Neurology Advisor Articles
- Combined Exercise Training Increases BDNF in Relapsing-Remitting MS
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Apheresis Associated With Clinical Improvement in Early Active Multiple Sclerosis
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Surgical Outcomes Associated With Trigger Site Deactivation for Migraines
- A Convenient Truth: The Problem With Seizure Under-Reporting and How to Fix It
- Incidence of Serotonin Syndrome With Co-Prescription of Triptans, Antidepressants
- Idiopathic Parkinson Disease May Increase Risk for Overactive Bladder
- Palliative Care in Movement Disorders: Recommendations for Improvement
- Cannabinoids May Be Effective as Adjunctive Treatment for Refractory Epilepsy